Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:SESN

Sesen Bio (SESN) Stock Price, News & Analysis

Sesen Bio logo

About Sesen Bio Stock (NASDAQ:SESN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.63
$12.99
52-Week Range
N/A
Volume
93,330 shs
Average Volume
1.07 million shs
Market Capitalization
$2.56 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SESN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sesen Bio and its competitors with MarketBeat's FREE daily newsletter.

SESN Stock News Headlines

Trey Mewes
Sesen Bio (NASDAQ: SESN)
Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
See More Headlines

SESN Stock Analysis - Frequently Asked Questions

Sesen Bio, Inc. (NASDAQ:SESN) announced its quarterly earnings results on Sunday, November, 7th. The company reported $7.20 EPS for the quarter, beating analysts' consensus estimates of ($1.40) by $8.60.

Sesen Bio shares reverse split on Wednesday, March 8th 2023.The 1-20 reverse split was announced on Wednesday, March 8th 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, March 8th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sesen Bio investors own include Predictive Oncology (POAI), Ford Motor (F), Zomedica (ZOM), NIO (NIO), Bank of America (BAC), Wells Fargo & Company (WFC) and OPKO Health (OPK).

Company Calendar

Last Earnings
11/07/2021
Today
7/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:SESN
CIK
1485003
Employees
35
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.10)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$19.88 million
Net Margins
N/A
Pretax Margin
-59.40%
Return on Equity
6.70%
Return on Assets
5.41%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.10
Quick Ratio
6.10

Sales & Book Value

Annual Sales
$40 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
3.39
Book Value
$0.78 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
203,490,000
Free Float
196,980,000
Market Cap
$2.56 billion
Optionable
Optionable
Beta
0.83
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:SESN) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners